It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
https://arctichealth.org/en/permalink/ahliterature22646
Source
Bone Marrow Transplant. 1996 May;17 Suppl 3:S63-4
Publication Type
Article
Date
May-1996
More detail
Author
B. Simonsson
G. Oberg
M. Björeman
M. Björkholm
J. Carneskog
G. Gahrton
R. Hast
H. Karl
J. Lanng-Nielsen
E. Löfvenberg
C. Malm
I. Turesson
A M Udén
L. Vilén
O. Weis-Bjerrum
Author Affiliation
Department of Medicine, University Hospital, Uppsala, Sweden.
Source
Bone Marrow Transplant. 1996 May;17 Suppl 3:S63-4
Date
May-1996
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Bone Marrow Transplantation
Combined Modality Therapy
Denmark
Female
Humans
Hydroxyurea - therapeutic use
Interferon-alpha - therapeutic use
Leukemia, Myeloid, Chronic - drug therapy - genetics - therapy
Leukemia, Myeloid, Philadelphia-Positive - drug therapy - genetics - therapy
Male
Middle Aged
Philadelphia Chromosome
Sweden
Transplantation, Autologous
Transplantation, Homologous
Abstract
With the rationale that a significant reduction of the malignant clone in CML might prolong time to metamorphosis, intensive treatment was given to patients
PubMed ID
8769705
View in PubMed
Less detail
Permalink